Jingxiang Y. Zhong
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
SSGJ-601 versus Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion: 52-Week Results from a Phase 3 Study.
Journal: Ophthalmology. Retina
Published: March 30, 2026
Integrated Bioinformatics Analysis of a TF-miRNA-mRNA Regulatory Network in Retinal Vein Occlusion with Metabolic Syndrome and its Association with Clinical Predictors.
Journal: Current eye research
Published: February 27, 2026
Dual-SwinOrd: A Dual-Head Swin Transformer with Semantic Prior Injection for Ordinal Diabetic Retinopathy Grading.
Journal: Bioengineering (Basel, Switzerland)
Published: February 21, 2026
Regulatory mechanisms and therapeutic potential of N6-methyladenosine modification in retinal diseases (Review).
Journal: Molecular medicine reports
Published: January 13, 2026
Corneal transcriptomic signatures of mycotoxin exposure reveal distinct immune and metabolic responses.
Journal: Ecotoxicology and environmental safety
Published: December 04, 2025
Fusarium solani Activates PANoptosis and Modulates Immune Response in Fungal Keratitis.
Journal: Investigative ophthalmology & visual science
Published: October 16, 2025
Clofarabine Enhances the Transduction Efficiency of Recombinant AAV2 in the Retina.
Journal: Investigative ophthalmology & visual science
Published: May 28, 2025
Efficacy and safety of anti-VEGF monoclonal antibody 601 for macular oedema in retinal vein occlusion: two phase IIa randomised clinical trials.
Journal: The British journal of ophthalmology
Published: May 22, 2025
Aquaporin-4 triggers inflammation in a murine endotoxin-induced uveitis (EIU) model.
Journal: BMC ophthalmology
Published: April 23, 2025
Multimodal data-driven approaches in retinal vein occlusion: A narrative review integrating machine learning and bioinformatics.
Journal: Advances in ophthalmology practice and research
Published: March 30, 2025
Treat-And-Extend Versus Pro Re Nata Regimen of Intravitreal Conbercept Injection for Neovascular Age-Related Macular Degeneration: Results from COCOA, a Prospective, Open-Label, Multicenter, Randomized Phase IV Clinical Trial.
Journal: Seminars in ophthalmology
Published: March 13, 2025
Construction and validation of risk prediction models for different subtypes of retinal vein occlusion.
Journal: Advances in ophthalmology practice and research
Published: November 12, 2024
Last Updated: 09/26/2026